Biopharm

Project details

In December 2013, EuroMena II Limited Partnership acquired a minority stake in Biopharm, an Algerian pharmaceutical company that is vertically integrated, covering importation, distribution, direct distribution, and production of pharmaceutical products. In April 2016, 20% of the Company was listed on the Algiers Stock Exchange.

Profile:
Biopharm is the leading, local pharmaceutical company in Algeria. Core activities consist of import, distribution, wholesale and production of pharmaceutical products.

Main Business Lines:
Biopharm Spa: Production of more than 46 products under license.
Biopharm Distribution: Biopharm is a leader in distribution in Algeria, offering a wide and competitive set of services to its customers through importing pharmaceutical and para-pharmaceutical products to wholesalers.
Biopure Spa: Direct distribution of pharmaceutical and para-pharmaceutical products.
Biopharm Logistique: Storage and logistics
Human Health Information (HHI): Promotion of pharmaceutical, para-pharmaceutical, and veterinary products.